Castleman’s Disease - Causes, Types

Still choosing the right health plan?

We're here to guide you.

Castleman’s Disease Demystified: Classification, Pathology & Subtypes

 

Castleman’s disease is a rare disorder involving an overgrowth of cells in the lymph nodes. It is a rare lymphoproliferative disorder involving immune system dysregulation, which may secondarily affect blood parameters. This condition can cause symptoms like enlarged lymph nodes, fatigue, and fever, often mimicking blood-related disorders. 

  

Why is Castleman’s Disease Considered a Blood Disease? 

  

There are certain characteristics of Castleman's disease that confirm it is a blood disease. Here we will highlight those characteristics in detail: 

  

  • Lymph Nodes: The primary characteristic of Castleman disease is the enlargement of lymph nodes. They are a part of your lymphatic system and a crucial component of the immune and blood systems. 
  • Blood Abnormalities: Castleman’s disease may be associated with hematologic abnormalities (e.g., anaemia, thrombocytopenia or thrombocytosis) and secondary organ dysfunction, including renal impairment that can lead to elevated creatinine. 
  • Pathology: The microscopic examination of lymph nodes in Castleman’s disease highlights specific cellular changes and patterns. These lymph nodes exhibit morphological differences from normal lymph nodes. 
      

What are the Different Types of Castleman’s Disease? 

  

Castleman’s disease is mainly classified into two types: unicentric and multicentric. Unicentric Castleman’s disease involves a single, enlarged lymph node, often in the abdomen or chest region. On the other hand, multicentric Castleman’s disease affects multiple lymph node regions and can cause various complications. 

  

Let us discuss in detail the subtypes of these two categories of Castleman’s disease: 

  

  • POEMS-associated Multicentric Castleman Disease (POEMS-MCD): POEMS-associated multicentric Castleman’s disease is a rare condition where patients have both POEMS syndrome and multicentric Castleman’s disease. POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma disorder, and skin changes), along with MCD, involves nerve damage, organ enlargement and other endocrine problems. 
    Note: POEMS syndrome may be associated with Castleman disease in a subset of patients, but the two conditions do not universally coexist. 
  • HHV-8-associated Multicentric Castleman Disease (HHV-8+MCD): It is a lymphoproliferative disorder linked to human herpesvirus-8 (HHV-8) infection. This shows signs of enlarged lymph nodes in multiple regions, potential organ dysfunction, and systemic inflammatory symptoms. HHV-8-associated MCD is most diagnosed in individuals who are immunocompromised, particularly those with HIV/AIDS. While it can occur in HIV-negative individuals, this is far less common. 
  • HHV-8-negative/Idiopathic Multicentric Castleman Disease (iMCD): HHV-8-negative, or idiopathic multicentric Castleman’s disease, is a rare disorder exhibiting characteristics including systemic inflammation and organ dysfunction due to cytokine storm, particularly due to elevated levels of IL-6. HHV-8-negative, or idiopathic multicentric Castleman's disease (iMCD), is a distinct subtype not associated with the human herpesvirus-8 infection. Its exact cause remains unknown. 

  

What Causes Castleman’s Disease? 

  

The exact cause of CD is still not properly known and is under research. However, immunocompromised states, particularly HIV infection, are strongly associated with HHV‑8–positive multicentric Castleman disease, but other forms of Castleman’s disease often occur in immunocompetent individuals. These we will highlight in detail here: 

  

  • Cytokine Dysregulation: Abnormal levels of cytokines, signalling molecules that regulate immune responses, may contribute to abnormal cell growth and lead to Castleman’s disease symptoms, like inflammation. Increased production of interleukins in the bloodstream can result in chronic inflammation. 
  • Autoimmune Responses: Sometimes our body’s immune cells mistakenly attack our healthy, normal cells, leading to chronic inflammation and an immune response. Chronic inflammation can lead to the growth of abnormal cells and the formation of enlarged lymph nodes, leading to organ dysfunction. 
    Note: Autoimmune mechanisms have been proposed in some cases of idiopathic multicentric Castleman’s disease, but evidence remains inconclusive, and this is an area of ongoing research. 
  • Gene Mutations: Castleman’s disease is associated with excessive IL‑6 signalling, but specific causative gene mutations have not been definitively identified. Mutations in IL-6 and its receptors can cause overproduction of cytokines, leading to increased immune response and inflammation, which are common in Castleman’s disease. 

  

The exact mechanism and genes responsible for the development of Castleman’s disease are still under investigation. Future research may reveal genes and pathways responsible for the development and progression of it. 

  

Disclaimer: This article is intended for informational and educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Castleman’s disease is a rare and complex condition, and its presentation, causes, and management may vary from person to person. Consult a qualified healthcare professional for personalized medical advice, diagnosis, or treatment decisions. 

 

Also Read:

 

Cerebellum Dysfunction Symptoms & Causes Explained

 

Exploring the Root Causes of Cerebellar Ataxia

 

Fish Odour Syndrome - Types, Causes, Symptoms, Treatments

 

Von Hippel-Lindau Disease (VHL) - Causes, Effects, Prevention, Diagnosis

 

Systemic Scleroderma: Types, Causes, Symptoms, Diagnosis

Disclaimer:
Health Insurance Coverage for pre-existing medical conditions is subject to underwriting review and may involve additional requirements, loadings, or exclusions. Please disclose your medical history in the proposal form for a personalised assessment. 
This FAQ page contains information for general purpose only and has no medical or legal advice. For any personalized advice, do refer company's policy documents or consult a licensed health insurance agent. T & C apply. For further detailed information or inquiries, feel free to reach out via email at marketing.d2c@starhealth.in